XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue, net $ 913,571 $ 5,063,079 $ 6,659,858 $ 9,822,391
Cost of revenue 1,017,634 4,465,888 5,831,953 8,828,453
Gross profit (loss) (104,063) 597,191 827,905 993,938
Operating expenses:        
Advertising and marketing expenses 21,551 304,600 256,965 865,305
Product development costs 58,978 76,487 254,473
Selling, general and administrative expenses 681,448 1,292,746 2,452,305 3,684,617
Goodwill impairment charges 631,064
Total operating expenses 702,999 1,656,324 2,785,757 5,435,459
Operating loss (807,062) (1,059,133) (1,957,852) (4,441,521)
Other income (expense):        
Other income (expense), net 6,358 7,778 191,358
Interest income (expense), net 8,043 10,725 26,042 24,585
Total other income (expense) 8,043 17,083 33,820 215,943
Loss before provision for income taxes (799,019) (1,042,050) (1,924,032) (4,225,578)
Income taxes
Net loss (799,019) (1,042,050) (1,924,032) (4,225,578)
Convertible preferred series B stock dividends (35,984)
Deemed dividend on convertible preferred series B stock on down round (439,999)
Net loss available to common shareholders $ (799,019) $ (1,042,050) $ (1,924,032) $ (4,701,561)
Loss per common share - basic $ (0.10) $ (0.13) $ (0.24) $ (0.69)
Loss per common share - diluted $ (0.10) $ (0.13) $ (0.24) $ (0.69)
Weighted average number of common shares outstanding, basic 8,076,372 7,953,974 8,074,842 6,804,741
Weighted average number of common shares outstanding, diluted 8,076,372 7,953,974 8,074,842 6,804,741